IRIS
ZAPPULO, EMANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.387
EU - Europa 2.020
NA - Nord America 1.916
SA - Sud America 347
AF - Africa 82
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.757
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.803
SG - Singapore 1.304
RU - Federazione Russa 1.119
CN - Cina 585
IT - Italia 339
BR - Brasile 284
VN - Vietnam 181
HK - Hong Kong 154
NL - Olanda 136
DE - Germania 108
CA - Canada 65
FI - Finlandia 56
GB - Regno Unito 55
UA - Ucraina 45
IN - India 42
FR - Francia 37
AR - Argentina 32
MX - Messico 31
KR - Corea 30
IE - Irlanda 28
ZA - Sudafrica 24
PL - Polonia 21
BD - Bangladesh 19
CI - Costa d'Avorio 19
ES - Italia 15
ID - Indonesia 14
AT - Austria 13
JP - Giappone 13
SE - Svezia 13
EC - Ecuador 10
IQ - Iraq 10
EG - Egitto 8
MA - Marocco 8
CO - Colombia 7
LT - Lituania 7
TR - Turchia 6
TN - Tunisia 5
DZ - Algeria 4
MK - Macedonia 4
PK - Pakistan 4
SA - Arabia Saudita 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
DO - Repubblica Dominicana 3
KE - Kenya 3
PY - Paraguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
BE - Belgio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
JO - Giordania 2
LU - Lussemburgo 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 6.754
Salva come PNG Salva come JPEG
Città #
Singapore 618
Moscow 283
Ashburn 240
Hefei 190
Chandler 179
Beijing 162
Hong Kong 154
Santa Clara 120
Amsterdam 116
Naples 101
Los Angeles 83
Ho Chi Minh City 58
Millbury 57
New York 53
Munich 39
Des Moines 37
Dallas 36
São Paulo 35
Hanoi 34
Napoli 31
Ottawa 31
Seoul 30
Redondo Beach 28
Boston 27
Buffalo 27
The Dalles 26
Lawrence 25
Princeton 23
Seattle 22
Nanjing 19
Turku 18
Boardman 17
Chicago 17
Warsaw 17
Montreal 16
Helsinki 14
Nuremberg 14
Orem 14
Wilmington 14
Mexico City 13
Tokyo 13
Johannesburg 11
Phoenix 11
Poplar 11
Rome 11
Stockholm 11
Brooklyn 10
Da Nang 10
Denver 10
Frankfurt am Main 10
Houston 10
Chennai 9
Milan 9
Porto Alegre 9
Toronto 9
Council Bluffs 8
Düsseldorf 8
London 8
Manchester 8
Querétaro 8
Atlanta 7
Baghdad 7
Bologna 7
Charlotte 7
Rio de Janeiro 7
Fisciano 6
Hebei 6
Nanchang 6
Pune 6
San Francisco 6
Tianjin 6
Biên Hòa 5
Cairo 5
Curitiba 5
Falkenstein 5
Lappeenranta 5
Parma 5
Washington 5
Boydton 4
Campinas 4
Casablanca 4
Columbus 4
Dhaka 4
Dong Ket 4
Dublin 4
Guarulhos 4
New Delhi 4
Pomigliano D'arco 4
Qualiano 4
Salvador 4
Shanghai 4
Skopje 4
Vancouver 4
Wuhan 4
Ankara 3
Brescia 3
Buenos Aires 3
Caxias do Sul 3
Concórdia 3
Dung 3
Totale 3.420
Salva come PNG Salva come JPEG
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 155
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 134
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 130
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 129
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 128
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 124
Diabetes and COVID-19: The potential role of mTOR 122
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 121
Asunaprevir for hepatitis C: A safety evaluation 119
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 118
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 114
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 113
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 111
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 110
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 110
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 109
Infezione da cytomegalovirus 109
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 108
Trabecular bone score assessed by dual-energy X ray absorption predicts vertebral fractures in HIV infected young adults 106
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 106
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 105
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 104
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 104
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 104
Beclabuvir for the treatment of hepatitis C 103
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 103
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 102
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 102
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 101
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 101
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 101
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 101
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 100
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 100
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 100
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 99
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 99
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 98
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 98
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 98
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 97
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 96
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 95
DNA detection of herpetic viruses in dried blood spots in children with autism spectrum disorders 95
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 95
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study (Journal of Neurology, (2022), 269, 6, (3301-3307), 10.1007/s00415-022-11009-x) 94
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 94
Pre-exposure prophylaxis for COVID-19 with Tixagevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience 92
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 91
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 91
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 91
Il Virus varicella Zoster 90
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 89
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis 88
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 87
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 86
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 85
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 84
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience 82
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 81
Epstein-Barr virus 77
Response to measles-mumps-rubella vaccine in children with autistic spectrum disorders 77
Prevalence of human herpesvirus-6 and epstein barr virus infections in children with autistic spectrum disorders 76
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 76
Pharmacological approaches to prevent vertical transmission of HIV and HBV 73
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 71
HSV 71
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center 63
The role of curcumin in liver diseases 47
No evidence of congenital varicella zoster virus infection assessed through dried blood spot in children with autism spectrum disorders 42
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis 35
Totale 6.910
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.738
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 7 8 3 16 17 1 7
2021/2022290 5 3 3 2 1 12 1 10 27 30 77 119
2022/2023517 51 31 20 35 55 61 14 50 62 114 20 4
2023/2024408 14 65 76 30 22 68 3 35 7 7 43 38
2024/20252.330 85 73 11 43 71 141 213 127 152 268 952 194
2025/20262.931 496 332 579 492 838 194 0 0 0 0 0 0
Totale 6.910